Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.06
-0.13 (-1.74%)
Dec 29, 2025, 1:53 PM EST - Market open
Organon & Co. Revenue
Organon & Co. had revenue of $1.60B in the quarter ending September 30, 2025, with 1.26% growth. This brings the company's revenue in the last twelve months to $6.30B, down -1.69% year-over-year. In the year 2024, Organon & Co. had annual revenue of $6.40B with 2.24% growth.
Revenue (ttm)
$6.30B
Revenue Growth
-1.69%
P/S Ratio
0.29
Revenue / Employee
$630,100
Employees
10,000
Market Cap
1.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.40B | 140.00M | 2.24% |
| Dec 31, 2023 | 6.26B | 89.00M | 1.44% |
| Dec 31, 2022 | 6.17B | -130.00M | -2.06% |
| Dec 31, 2021 | 6.30B | -228.00M | -3.49% |
| Dec 31, 2020 | 6.53B | -1.25B | -16.01% |
| Dec 31, 2019 | 7.78B | -2.00B | -20.46% |
| Dec 31, 2018 | 9.78B | -723.00M | -6.89% |
| Dec 31, 2017 | 10.50B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OGN News
- 26 days ago - Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Organon To Present at the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 6 weeks ago - Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US - Business Wire
- 6 weeks ago - Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect - Seeking Alpha
- 6 weeks ago - Organon Analysts Cut Their Forecasts Following Q3 Results - Benzinga
- 7 weeks ago - Organon & Co. (OGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Organon Reports Results for the Third Quarter Ended September 30, 2025 - Business Wire
- 7 weeks ago - Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie - Business Wire